# A Survey of Physician and Molecular Tumor Board Perspectives on the Clinical Utility and Usability of Cellworks Singula™ and Ventura™ Reports in Facilitating Patient Treatment Decisions for Pan-Cancer Patients

> **NCT05308784** · — · UNKNOWN · sponsor: **Avera McKennan Hospital & University Health Center** · enrollment: 730 (estimated)

## Conditions studied

- Pan-cancer

## Interventions

- **OTHER:** Cellworks Singula and Ventura reports

## Key facts

- **NCT ID:** NCT05308784
- **Lead sponsor:** Avera McKennan Hospital & University Health Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 730 (ESTIMATED)
- **Last updated:** 2023-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05308784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05308784, "A Survey of Physician and Molecular Tumor Board Perspectives on the Clinical Utility and Usability of Cellworks Singula™ and Ventura™ Reports in Facilitating Patient Treatment Decisions for Pan-Cancer Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05308784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*